wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q46311055-4F51EADC-E972-4CAD-BC47-B82859C8DA75
Q46311055-4F51EADC-E972-4CAD-BC47-B82859C8DA75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46311055-4F51EADC-E972-4CAD-BC47-B82859C8DA75
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
P2860
Q46311055-4F51EADC-E972-4CAD-BC47-B82859C8DA75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46311055-4F51EADC-E972-4CAD-BC47-B82859C8DA75
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2fa9cade1724841412a6b9e77f6b5c3a78808ea1
P2860
Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99].